SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-22-000915
Filing Date
2022-04-14
Accepted
2022-04-14 17:00:45
Documents
54
Period of Report
2022-02-28

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20220228x10q.htm   iXBRL 10-Q 1002926
2 EX-31.1 tmb-20220228xex31d1.htm EX-31.1 13984
3 EX-32.1 tmb-20220228xex32d1.htm EX-32.1 5748
  Complete submission text file 0001410578-22-000915.txt   4323928

Data Files

Seq Description Document Type Size
4 EX-101.SCH tmb-20220228.xsd EX-101.SCH 40787
5 EX-101.CAL tmb-20220228_cal.xml EX-101.CAL 29897
6 EX-101.DEF tmb-20220228_def.xml EX-101.DEF 164201
7 EX-101.LAB tmb-20220228_lab.xml EX-101.LAB 325349
8 EX-101.PRE tmb-20220228_pre.xml EX-101.PRE 256842
48 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20220228x10q_htm.xml XML 599815
Mailing Address 366 MADISON AVE. 3RD FLOOR NEW YORK NY 10017
Business Address 366 MADISON AVE. 3RD FLOOR NEW YORK NY 10017 212-588-0022
Q BioMed Inc. (Filer) CIK: 0001596062 (see all company filings)

IRS No.: 464013793 | State of Incorp.: NV | Fiscal Year End: 1130
Type: 10-Q | Act: 34 | File No.: 000-55535 | Film No.: 22828043
SIC: 2834 Pharmaceutical Preparations